Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
ODT
Sort By
Newest First
1 / 1
1 / 1
Sweeteners
High-Intensity Sweeteners for Taste Optimization
Almut von der Brelie
MilliporeSigma
PAO-11-022-CL-12
Nov 28, 2022
Migraine
Biohaven Announces NURTEC® ODT Receives First Global Approval Outside the U.S. For Prevention of Migraine
Biohaven
PR-M12-21-01
Dec 13, 2021
Orally Disintegrating Tablets
A Revolutionary Excipient Platform for Super-Fast Disintegrating ODTs
Bill McCarthy; Geetha Thanga Mariappan, Ph.D.
SPI Pharma
PAO-07-21-CL-03
Jul 13, 2021
Orally Disintegrating Tablets
Qualifying ODT Excipient Systems Beyond Disintegration Performance
Adela Kasselkus, Ph.D.; Hans-Leonhard Ohrem
MilliporeSigma
PAO-10-20-CL-03
Oct 27, 2020
